The weed and root killer Roundup™, which is currently the most popular and best selling herbicide in the world, is being investigated for claims that its active ingredient “glyphosate” may be linked to an increased risk of cancer, or more specifically, non-Hodgkin’s Lymphoma (NHL). Plaintiffs also claim that the product’s manufacturer, Monsanto, failed to sufficiently warn its users of these increased risks in order to avoid profit losses, as the company has known of the link between its product and potential cancer cases for more than 30 years.
Lawsuits filed against Monsanto (the manufacturer of Roundup™) contain a combination of the following allegations:
Only B cell or T cell non-Hodgkin’s Lymphoma (“NHL”) or its subtypes:
NHL/cancer diagnosis must be at least 12 months after initial use. The official criteria has yet to be determined, so any injury you may have suffered due to Roundup exposure could qualify.
If you’ve been exposed to Roundup™ and feel you match the listed criteria above, you may be eligible to receive compensation for damages suffered, medical expenses, or lost work wages. Contact us immediately or give us a call to find out more (800-229-7704).
Page last reviewed and updated: October 8, 2019